Introduction: Gastric adenocarcinoma is the fourth most common cancer worldwide (7.8% of cancers) but the second leading cause of cancer death (9.7% of cancer deaths). The 5-year survival for advanced/metastatic gastric cancer is less than 10% and, despite the recent development of new chemotherapy regimens and the introduction of biologic therapy, median overall survival remains less than 1 year. Methods: It was a retrospective study of 113 metastatic gastric adenocarcinoma patients treated between 2010 and 2014 at Rouiba medical oncology department. Median age was 60.5 years, 42 women with a median age 55 years and 71 men with a median age of 61 years .

No abstract

Conclusion: Elevated postoperative CEA following resection of CRC predicted relapse. However, high preoperative CEA levels that normalized after CRC surgery was not associated with higher relapse.Legal entity responsible for the study: Department of medical oncology.

No abstract